This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (12) Citing Articles via Google Scholar Google Scholar Articles by Ganter, M. T. Articles by Hofer, C. K. Search for Related Content PubMed PubMed Citation Articles by Ganter, M. T. Articles by Hofer, C. K. Related Collections Cardiovascular Monitoring (Cardiac) Coagulation

---

CARDIOVASCULAR ANESTHESIOLOGY

Coagulation Monitoring: Current Techniques and Clinical Use of Viscoelastic Point-of-Care Coagulation Devices

Michael T. Ganter, MD^*, and Christoph K. Hofer, MD

From the *Department of Anesthesia and Perioperative Care University of CA San Francisco, San Francisco California; and Institute of Anesthesiology and Intensive Care Medicine, Triemli City Hospital Zurich, Switzerland.

Address correspondence and reprint requests to Christoph K. Hofer, MD, Institute of Anesthesiology and Intensive Care Medicine, Triemli City Hospital Zurich, Birmensdorferstr. 497,8063 Zurich, Switzerland. Address e-mail to christoph.hofer{at}triemli.stzh.ch.

Abstract

Perioperative monitoring of blood coagulation is critical to better understand causes of hemorrhage, to guide hemostatic therapies, and to predict the risk of bleeding during the consecutive anesthetic or surgical procedures. Point-of-care (POC) coagulation monitoring devices assessing the viscoelastic properties of whole blood, i.e., thrombelastography, rotation thrombelastometry, and Sonoclot® analysis, may overcome several limitations of routine coagulation tests in the perioperative setting. The advantage of these techniques is that they have the potential to measure the clotting process, starting with fibrin formation and continue through to clot retraction and fibrinolysis at the bedside, with minimal delays. Furthermore, the coagulation status of patients is assessed in whole blood, allowing the plasmatic coagulation system to interact with platelets and red cells, and thereby providing useful additional information on platelet function. Viscoelastic POC coagulation devices are increasingly being used in clinical practice, especially in the management of patients undergoing cardiac and liver surgery. Furthermore, they provide useful information in a large variety of clinical scenarios, e.g., massive hemorrhage, assessment of hypo- and hypercoagulable states, guiding pro- and anticoagulant therapies, and in diagnosing of a surgical bleeding. A surgical etiology of bleeding has to be considered when viscoelastic test results are normal. In summary, viscoelastic POC coagulation devices may help identify the cause of bleeding and guide pro- and anticoagulant therapies. To ensure optimal accuracy and performance, standardized procedures for blood sampling and handling, strict quality controls and trained personnel are required.

This article has been cited by other articles:

				J. H. Levy, R. P. Dutton, J. C. Hemphill III, A. Shander, D. Cooper, M. J. Paidas, C. M. Kessler, J. B. Holcomb, J. H. Lawson, and for the Hemostasis Summit Participants Multidisciplinary Approach to the Challenge of Hemostasis Anesth. Analg., February 1, 2010; 110(2): 354 - 364. [Abstract] [Full Text] [PDF]

				K. C. Sihler and L. M. Napolitano Massive Transfusion: New Insights Chest, December 1, 2009; 136(6): 1654 - 1667. [Abstract] [Full Text] [PDF]

				L. J. Enriquez and L. Shore-Lesserson Point-of-care coagulation testing and transfusion algorithms Br. J. Anaesth., December 1, 2009; 103(suppl_1): i14 - i22. [Abstract] [Full Text] [PDF]

				C. Jambor, V. Reul, T. W. Schnider, P. Degiacomi, H. Metzner, and W. C. Korte In Vitro Inhibition of Factor XIII Retards Clot Formation, Reduces Clot Firmness, and Increases Fibrinolytic Effects in Whole Blood Anesth. Analg., October 1, 2009; 109(4): 1023 - 1028. [Abstract] [Full Text] [PDF]

				M. Carey and D. M. Cressey Hyperfibrinolysis - is it common? Measurement and treatment including the role of thromboelastography Clin Risk, September 1, 2009; 15(5): 188 - 191. [Full Text] [PDF]

				W. C. Oliver Anticoagulation and Coagulation Management for ECMO Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2009; 13(3): 154 - 175. [Abstract] [PDF]

				M. Hartmann Priv Doz D, S. Ozlugedik, and J. Peters Thiopental Inhibits Lipopolysaccharide-Induced Tissue Factor Expression Anesth. Analg., July 1, 2009; 109(1): 109 - 113. [Abstract] [Full Text] [PDF]

				K. A. Tanaka, N. S. Key, and J. H. Levy Blood Coagulation: Hemostasis and Thrombin Regulation Anesth. Analg., May 1, 2009; 108(5): 1433 - 1446. [Abstract] [Full Text] [PDF]

				J. Boldt, S. Suttner, C. Brosch, A. Lehmann, and A. Mengistu Influence on coagulation of a potato-derived hydroxethylstarch (HES 130/0.42) and a maize-derived hydroxethylstarch (HES 130/0.4) in patients undergoing cardiac surgery Br. J. Anaesth., February 1, 2009; 102(2): 191 - 197. [Abstract] [Full Text] [PDF]

				B. Steinlechner, M. Dworschak, B. Birkenberg, M. Duris, P. Zeidler, H. Fischer, L. Milosevic, G. Wieselthaler, E. Wolner, P. Quehenberger, et al. Platelet Dysfunction in Outpatients With Left Ventricular Assist Devices Ann. Thorac. Surg., January 1, 2009; 87(1): 131 - 137. [Abstract] [Full Text] [PDF]

				C. K. Hofer and M. T. Ganter Coagulation Monitoring Anesth. Analg., December 1, 2008; 107(6): 2093 - 2094. [Full Text] [PDF]